Dolby Laboratories
DLB-
Dolby Laboratories edged up 0.6% to $64.96 after the audio and imaging company's fiscal first-quarter outlook fell short of market expectations.
Revenue in the fiscal fourth quarter ending in September increased to $307 million from $305 million, net attributable income plunged to $49.3 million from $58.6 million, and diluted earnings per share dropped to 51 cents from 61 cents a year ago.
Nov 19, 2025 -
Dolby Laboratories soared 11.5% to $81.19 after the audio and imaging technology provider reported better-than-expected quarterly earnings in the fiscal fourth quarter ending in September.
Revenue increased to $304.8 million from $290.5 million, net income advanced to $58.6 million from $9.2 million, and diluted earnings per share rose to 61 cents from 9 cents a year earlier.
Nov 20, 2024
|
|
| |
|
| Trading Volume | 33,273 |
|
|
89.41 - 66.76 |
| Market Cap Full | $ 6.9B |
Quarterly +
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Q1 | -22.9% | 0.1% | -2.8% | 21.1% |
| Q2 | - | 19.8% | -5.2% | -2% |
| Q3 | - | 19.8% | -9.2% | -5.3% |
| Q4 | - | 19.8% | 3% | 6.9% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2026 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | |||||||||||
| 0.1 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -3.5 | -2.6 | 3.4 | -6.7 | 3.7 | -2.3 | -0.6 | -9.2 | - | - | - | -0.4 |
| 2023 | |||||||||||
| 12.8 | 3.5 | 3.8 | -2 | -1.3 | 1.3 | 5.8 | -4.7 | -6.1 | 2.1 | 6.4 | 0 |
| 2022 | |||||||||||
| -7.7 | -14.5 | 5 | -1.7 | 0.2 | -7.8 | 8.2 | -5.4 | -11.1 | 2.2 | 12.4 | -5.8 |
| 2021 | |||||||||||
| -9.4 | 10.9 | 1.1 | 2.8 | -3.9 | 0.8 | -1.2 | 2.1 | -11.2 | 0.4 | -5.6 | 14.2 |
EPS
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Q1 | 1 | 0.4 | 0.7 |
| Q2 | 0.2 | 0.4 | 0.5 |
| Q3 | 0.1 | 0.3 | 0.4 |
| Q4 | 0 | 0.8 | 0.8 |
| A | 2.1 | 1.8 | 3 |